Sbi Securities Co., Ltd. C4 Therapeutics, Inc. Put Options Transaction History
Sbi Securities Co., Ltd.
- $3 Trillion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CCCC
# of Institutions
123Shares Held
63.3MCall Options Held
18.8KPut Options Held
0-
Lynx1 Capital Management LP San Juan, PR7.1MShares$14.3 Million4.2% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT6.98MShares$14 Million0.92% of portfolio
-
Orbimed Advisors LLC San Diego, CA6.83MShares$13.7 Million0.34% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT6.72MShares$13.5 Million0.06% of portfolio
-
Black Rock Inc. New York, NY4.55MShares$9.15 Million0.0% of portfolio
About C4 Therapeutics, Inc.
- Ticker CCCC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,913,800
- Market Cap $98.3M
- Description
- C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...